1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea
CAS: 1333390-56-9
Ref. 3D-IDC39056
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
Regorafenib is a multikinase inhibitor that inhibits the activity of kinases in the RAS-RAF-MEK-ERK pathway, which are enzymes that regulate cell proliferation. It is an oral drug used to treat patients with metastatic colorectal cancer who have been previously treated with chemotherapy. The target of regorafenib is the oncogenic kinases in the RAS-RAF-MEK-ERK pathway, which are important for tumor growth and progression. Regorafenib has shown efficacy against many different types of cancers, including colorectal, thyroid, lung and renal cancers.
Propriedades químicas
Consulta técnica sobre: 3D-IDC39056 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
